# Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck

> **NCT02075112** · PHASE1 · COMPLETED · sponsor: **Emory University** · enrollment: 24 (actual)

## Conditions studied

- Cancer of Head and Neck

## Interventions

- **DRUG:** Soy isoflavone
- **RADIATION:** Radiation
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT02075112
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2019-09
- **Final completion:** 2019-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02075112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02075112, "Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02075112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*